Impact of Invasive Mold Infection–Coded Diagnoses on Utilization, Costs, and Mortality After Lung Transplantation
@MayoClinicINFD@MayoTransplant
CHEST https://t.co/aFOqXtjEU2
Publication alert 🚨 This study, led by our fellow Dr. Mughrabi, describes the clinical outcomes of letermovir use as primary and secondary prophylaxis against cytomegalovirus in non-kidney solid organ transplant recipients. https://t.co/KcN6oNRNtS
Congratulations to the team!
Depletional induction = risk of BK recurrence; non-depletional induction = risk of rejection. Long-term outcome: similar! Great work led by Dr. Riad @SamyRiad9
Induction Regimens and Kidney Re‐Transplant Outcomes after BK Nephropathy–Related Graft Loss: A U.S. Cohort Study @MayoClinicINFD@MayoTransplant@MayoClinicNeph https://t.co/HDLwmXNusc
Risk Factors and Outcomes of Pneumocystis jirovecii pneumonia in Kidney Transplant Recipients: A Case-Control Study of the United States Renal Data System - American Journal of Transplantation https://t.co/3jLSynNpUv
Congratulations @MariAleMendozaD@dfrieds89@pascalisID
Fellows expressing gratitude to our amazing Program Director @RazonableMD who will be rotating out of his role. Thank you for your leadership, advocacy and support for fellow education!
Our fantastic senior infectious disease fellow @MKerkelis presenting her work on parainfluenza infections in solid organ transplant recipients at the World Transplant Conference 2025. Great work supported by mentors @RazonableMD@nischalR3
Neurological disease is the most frequent syndrome of post-transplant HHV-6. Early recognition of limbic involvement through triad of confusion, amnesia and seizures or compatible MRI findings may help with early diagnosis. The sequelae can be disabling.
https://t.co/DjjwjkcAiN